New directions in science and business at Health Diagnostic Laboratory, Inc. (HDL, Inc.), and opportunities for collaboration
Details: Health Diagnostic Laboratory, Inc. (“HDL, Inc.”) in under five years has grown from a few founders to more than 700 employees and two six-story laboratory facilities in the Virginia BioTechnology Research Park in Richmond. HDL, Inc. provides the most comprehensive laboratory test menu of biomarkers and risk factors available, enabling patients and their doctors to practice proactive health and medicine. HDL, Inc. is reinventing the blood lab industry, and making major contributions to patient outcomes across the country and world, particularly in cardiovascular and related disease and diabetes. As HDL’s experience, capabilities and resources have grown, its passion for innovation and for making a difference in personal health management around the world is leading it to explore new and additional technologies and unmet needs, through in licensing, joint ventures and other collaborative models. In this panel, business and science leaders from HDL will describe recent collaborations, and identify directions, goals and needs of the company going forward with an emphasis on areas of potential collaboration.
Speakers: Dr. Szilard Voros, Chief Clinical Strategy Officer- HDL, Inc.; Mark Herzog, SVP, Corporate and Governmental Affairs- HDL, Inc.; and Brad Brown, VP, Clinical Affairs- Global Genomics Group